发明申请
US20160076031A1 PHOSPHOROUS-LINKED OLIGOMERIC COMPOUNDS AND THEIR USE IN GENE MODULATION
有权
磷酸二酯化合物及其在基因调控中的应用
- 专利标题: PHOSPHOROUS-LINKED OLIGOMERIC COMPOUNDS AND THEIR USE IN GENE MODULATION
- 专利标题(中): 磷酸二酯化合物及其在基因调控中的应用
-
申请号: US14834873申请日: 2015-08-25
-
公开(公告)号: US20160076031A1公开(公告)日: 2016-03-17
- 发明人: Brenda F. Baker , Anne B. Eldrup , Muthiah Manoharan , Balkrishen Bhat , Richard H. Griffey , Eric E. Swayze , Thazha P. Prakash
- 申请人: Isis Pharmaceuticals, Inc.
- 申请人地址: US CA Carlsbad
- 专利权人: ISIS PHARMACEUTICALS, INC.
- 当前专利权人: ISIS PHARMACEUTICALS, INC.
- 当前专利权人地址: US CA Carlsbad
- 主分类号: C12N15/113
- IPC分类号: C12N15/113
摘要:
Oligonucleotide compositions comprising first and second oligonucleotides are provided wherein at least a portion of the first oligonucleotide is capable of hybridizing with at least a portion of the second oligonucleotide, at least a portion of the first oligonucleotide is complementary to and capable of hybridizing to a selected target nucleic acid, and at least one of the first or second oligonucleotides includes at least one nucleotide having a modified phosphorous-containing internucleoside linkage. Oligonucleotide/protein compositions are also provided comprising an oligonucleotide complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex (RISC), wherein at least one nucleotide of the oligonucleotide has a modified phosphorous-containing internucleoside linkage.
公开/授权文献
信息查询
IPC分类: